What Artrosil Treats: Main Uses and Benefits

Artrosil (Ketoprofen) is commonly used across domains where short-term symptom management is appropriate, applied in clinical settings that involve acute or unstable symptom patterns, and relevant for easing conditions presenting with systemic or localized discomfort. The medication is applied in conditions marked by periods of heightened symptoms, including Osteoarthritis, Rheumatoid Arthritis, soft tissue trauma (like sprains and strains), and recurrent discomfort such as Primary Dysmenorrhea.

The core benefit is symptomatic support, helping to address symptom clusters that may become intense or disruptive, specifically pain, inflammation, and fever. It is applied in managing temporary acute pain associated with postoperative or dental procedures, assisting with maintaining functional stability during periods of discomfort. The medication offers supportive relief that helps patients cope more steadily with symptom fluctuations.

---

Quick Fact: Relief for Pain, Inflammation, and Fever Artrosil is commonly used to provide symptomatic relief in situations where patients experience these three common symptoms together, offering support that helps patients cope more steadily with symptom fluctuations.

Regulatory References

1. Health Canada Product Monograph

Eligibility Map: Official Regulatory Information

Populations for whom use is contraindicated: Artrosil (ketoprofen) is strictly contraindicated by regulatory authorities in several patient groups:

• Patients with a known history of hypersensitivity or allergic reactions to ketoprofen, aspirin, or any other Non-Steroidal Anti-Inflammatory Drug (NSAID).
• Patients with active peptic ulcer or a history of recurrent gastrointestinal bleeding or perforation.
• Women in the third trimester of pregnancy (after 28 weeks) due to risk of fetal harm.
• Patients in the setting of peri-operative pain for Coronary Artery Bypass Graft (CABG) surgery.
• Patients with severe, uncontrolled heart failure or severely impaired renal or hepatic function.

Age-Related Eligibility Rules: Safety and effectiveness are generally not established in the pediatric population (children and adolescents). For most systemic forms, use is not recommended below the age of 15 to 18 years, depending on the regulatory region and formulation.

Conditional and Restricted Use: Use requires caution, close monitoring, or dose adjustment in older adults, who are at increased risk for gastrointestinal adverse events and reduced kidney function. For women in the first and second trimesters of pregnancy, Artrosil should only be used if clearly necessary, employing the lowest effective dose for the shortest duration.

Interactions with other medicines and products

Artrosil (Ketoprofen) has officially documented interaction patterns primarily categorized as pharmacokinetic (PK) and pharmacodynamic (PD) reinforcement. The regulatory labeling outlines several mandatory restrictions and constraints based on these interactions.

The medicine is contraindicated for treating perioperative pain associated with coronary artery bypass graft (CABG) surgery and must not be co-administered with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or high-dose salicylates, due to a heightened risk of serious adverse events.

Pharmacodynamic and Exposure Interactions

Interacting Substance	Official Regulatory Outcome
Oral Anticoagulants, Corticosteroids, SSRIs	Increased risk of serious bleeding or gastrointestinal ulceration.
Lithium, Methotrexate	Risk of increased plasma levels and toxicity due to reduced renal clearance (Lithium) or altered elimination (Methotrexate). Methotrexate co-administration requires a separation of at least 12 hours.
Probenecid	Not recommended; substantially reduces Ketoprofen's plasma clearance, increasing exposure.
Diuretics and ACE Inhibitors	Diminished antihypertensive or natriuretic effects; increased risk of renal failure.
Food (High-Fat Meal)	Delays the time to reach peak plasma levels of the extended-release form.

These interaction requirements and constraints are often more pronounced in elderly and debilitated patients and those with renal impairment, where altered clearance can lead to increased systemic exposure. The overall profile focuses strictly on preventing the potentiation of risks inherent to the NSAID class.

Enzyme Inhibition and the Arachidonic Acid Cascade

The action of Ketoprofen is initiated by its role as a reversible competitive inhibitor of the Cyclooxygenase (COX) enzyme system (both COX-1 and COX-2). This enzymatic blockade suppresses a critical initial step in the synthesis of prostaglandins and thromboxanes, which are lipid mediators central to signaling. This mechanism is fundamental to modifying early molecular steps that influence systemic physiological changes.

Nociceptive and Thermoregulatory Modulation

Suppression of prostaglandin synthesis modulates multiple physiological systems. The reduction of PGE2 levels peripherally decreases the chemical sensitization of nociceptors, which reduces the influence of excessive mediator activity on nociceptive signaling. Centrally, the same inhibitory mechanism in the hypothalamus resets the body’s thermoregulatory set-point, contributing to the modulation of pathways responsible for core temperature control.

Stereoselectivity and Mechanism Nuance

The drug is administered as two mirror-image forms, or enantiomers, but the majority of the potent inhibitory action on COX enzymes is exerted by the S(+)-enantiomer. The mechanism involves non-selective inhibition, which includes the COX-1 isoform responsible for producing mediators required for physiological regulation, thereby engaging mechanisms that influence feedback regulation within pathways.

How to Use Artrosil: Official Administration Guidelines

The usage of Artrosil (Ketoprofen) is defined by established guidelines, which govern its route, dosage, frequency, and administration context. The foundational principle across all uses is to employ the lowest effective dose for the shortest possible duration.

---

Approved Dosing and Forms

Artrosil is available for systemic use via the oral (Immediate-Release and Extended-Release capsules), parenteral (injectable solution), and rectal (suppositories) routes, as well as for localized use via topical gel application.

Form Type	Standard Adult Dose / Max Daily Dose (Oral)
Immediate-Release (IR) Capsules	50 mg four times daily or 75 mg three times daily (Maximum 300 mg/day). Acute use is 25-50 mg every 6–8 hours as needed.
Extended-Release (ER) Capsules	200 mg once daily. This form is not intended for acute pain.
Topical Gel	Applied 2 to 4 times daily, typically for a maximum of 7 to 10 days (Maximum 15 g/day).

---

Administration Context and Special Rules

Oral Intake: Oral capsules may be taken with food, milk, or an antacid to assist with gastric tolerability. It is generally specified to take the capsule with a full glass of water and remain upright for at least 10 minutes after ingestion. The ER capsule must not be crushed or chewed to preserve its extended-release mechanism.

Topical Use: The gel must be gently massaged into the skin and is generally restricted from use under occlusive dressings.

Population Adjustments: Dosing in older adults should begin at the lower end of the dose range. Reductions in the maximum daily dose are mandatory for patients with renal or hepatic impairment.

Research Evidence: Overview of Studies for Artrosil (Ketoprofen)

Research Studies on Systemic Use for Rheumatic and Acute Pain

Research examined systemic use of Artrosil (ketoprofen) focusing on conditions marked by functional limitations and periods of heightened symptoms, such as Rheumatoid Arthritis (RA), Osteoarthritis (OA), and acute pain after procedures. Studies often utilized Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews to explore how symptoms change over defined time intervals. These trials monitored patient-reported outcomes describing perceived discomfort and functional status.

For RA and OA, research examined outcomes reflecting daily functioning and activity level, alongside measurements of pain intensity. Findings describe patterns observed in the studies regarding the evolution of patient-reported discomfort. However, there is limited information for long-term outcomes or sustained changes in symptomatic function beyond the intermediate follow-up periods.

Research Studies on Localized Use for Musculoskeletal Injuries

Research has explored the topical (gel) formulation of Artrosil for conditions characterized by fluctuating or episodic manifestations, such as localized injuries and pain. The evidence base relies on short-term RCTs and meta-analyses that specifically studied the application of the medicine directly to the skin. Research reports how symptoms evolved in the observed populations concerning short-term localized changes. The medicine was also studied for chronic conditions, such as localized Osteoarthritis pain, but there is limited information for long-term outcomes related to joint function.

What the Research Landscape Remains Uncertain About

While research has explored how symptoms change over time across various indications, the evidence highlights what is known—and what is still uncertain. Follow-up durations were limited in most key trials, meaning long-term effects are not fully established. Evidence quality varies across studies, and data for certain groups remain insufficient, including dedicated efficacy trials for older adults and pediatric patients.

Key Studies & References

1. Product Monograph (Health Canada) for Ketoprofen
2. Ketoprofen (Oral Route) - MedlinePlus, U.S. National Library of Medicine

Common questions about Artrosil (FAQ)

---

Q: If I forget to take my capsule, what should I do about the missed dose?

Official labeling advises taking the missed dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the patient is advised to skip the missed dose entirely. It is important to never take a double dose to make up for a dose that was forgotten.

---

Q: What are the common side effects that I should expect, like stomach upset?

According to the official product information, common side effects of Artrosil (ketoprofen) often involve the digestive system. These frequently reported issues can include stomach upset, nausea, vomiting, abdominal pain, or heartburn. Patients are advised to review the complete list of adverse reactions in the patient leaflet. Contacting a healthcare provider is recommended if symptoms are severe.

---

Q: How long does it typically take for Artrosil to start working to relieve pain?

Pharmacokinetic studies, which track how the body handles the medicine, indicate that the immediate-release form of Artrosil reaches its peak concentration in the blood within approximately 0.5 to 2 hours after being taken. This information relates to when the highest concentration of the drug is present in the bloodstream.

---

Q: I'm planning to have a surgery next month; should I stop taking Artrosil before the procedure?

Regulatory warnings for non-steroidal anti-inflammatory drugs (NSAIDs) like Artrosil suggest that caution or temporary discontinuation may be required before major surgery. This is due to the potential for an altered bleeding tendency. Patients should consult the healthcare team managing their procedure for specific guidance on stopping the medication.

---

Q: Can I drink alcohol while I am taking Artrosil?

Official documents often advise caution or avoidance of alcohol when Artrosil is being used. This is due to the potential for increased risk of serious gastrointestinal side effects, such as ulceration or bleeding, when the two substances are combined.

---

Q: What happens if I accidentally take too much Artrosil?

Official regulatory information describes potential symptoms of an overdose, which may include lethargy, vomiting, or stomach pain. Due to the risk of serious complications, such as internal bleeding or kidney failure, immediate medical attention should be sought if an overdose is suspected.

---

Q: What should I do if the topical gel accidentally gets into my eye?

The official product label specifies that contact with the eyes and mucous membranes must be avoided when using the topical gel. The label directs that if accidental contact occurs, the area should be washed thoroughly with water. If irritation persists, seeking medical advice is recommended.

How to Store and Dispose of Artrosil?

Artrosil (Ketoprofen) must be stored and disposed of strictly according to regulatory specifications to ensure product stability and safety.

Storage Requirements

Condition	Requirement
Temperature	Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), and do not freeze.
Protection	Keep in the original container, tightly closed, to protect from light and moisture.
Child Safety	Keep this medicine out of the sight and reach of children.
Stability	For certain liquid forms, the product must be discarded after a limited in-use period, such as 28 days after first opening.

Disposal

Unused or expired Artrosil must not be thrown away in household trash or disposed of via wastewater. All disposal must be carried out in accordance with local requirements for pharmaceutical products, often requiring return to a designated drug take-back or collection point.